Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Stewart

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Surgical Research|December 3, 2014
Determinants of 30-d readmission after colectomyAfif N Kulaylat, Peter W Dillon, Christopher S Hollenbeak, et al.
The Journal of Surgical Research|October 8, 2017
Palliative therapy for stage IV rectal adenocarcinoma: how frequently is it used?Audrey S Kulaylat, Emily B Rivet, Christopher S Hollenbeak, et al.
The Journal of Antibiotics|April 21, 2018
Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficileArun K Sharma, Jacek Krzeminski, Volkmar Weissig, et al.
The Journal of Surgical Research|October 29, 2017
Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitisRachel E Andrew, Alexis Lauria, Frances J Puleo, et al.
Diseases of the Colon and Rectum|December 8, 2016
Clinical Practice Guideline for the Management of Anal FissuresDavid B Stewart, Wolfgang Gaertner, Sean Glasgow, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 11, 2016
Induction and Purification of C. difficile Phage Tail-Like ParticlesJohn P Hegarty, William Sangster, Robert E Ashley, et al.
Annals of Surgical Oncology|November 28, 2012
Rectal cancer and teaching hospitals: hospital teaching status affects use of neoadjuvant radiation and survival for rectal cancer patientsDavid B Stewart, Christopher Hollenbeak, Susan Desharnais, et al.
Diseases of the Colon and Rectum|August 10, 2019
The Authors ReplyDavid B Stewart, Wolfgang Gaertner, Sean C Glasgow, et al.
International Journal of Nanomedicine|August 19, 2016
Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficileJohn P Hegarty, Jacek Krzeminski, Arun K Sharma, et al.
Diseases of the Colon and Rectum|December 17, 2010
Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAALiam A Haveran, Rishabh Sehgal, Lisa S Poritz, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Surgical Research|December 3, 2014
Determinants of 30-d readmission after colectomyAfif N Kulaylat, Peter W Dillon, Christopher S Hollenbeak, et al.
The Journal of Surgical Research|October 8, 2017
Palliative therapy for stage IV rectal adenocarcinoma: how frequently is it used?Audrey S Kulaylat, Emily B Rivet, Christopher S Hollenbeak, et al.
The Journal of Antibiotics|April 21, 2018
Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficileArun K Sharma, Jacek Krzeminski, Volkmar Weissig, et al.
The Journal of Surgical Research|October 29, 2017
Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitisRachel E Andrew, Alexis Lauria, Frances J Puleo, et al.
Diseases of the Colon and Rectum|December 8, 2016
Clinical Practice Guideline for the Management of Anal FissuresDavid B Stewart, Wolfgang Gaertner, Sean Glasgow, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 11, 2016
Induction and Purification of C. difficile Phage Tail-Like ParticlesJohn P Hegarty, William Sangster, Robert E Ashley, et al.
Annals of Surgical Oncology|November 28, 2012
Rectal cancer and teaching hospitals: hospital teaching status affects use of neoadjuvant radiation and survival for rectal cancer patientsDavid B Stewart, Christopher Hollenbeak, Susan Desharnais, et al.
Diseases of the Colon and Rectum|August 10, 2019
The Authors ReplyDavid B Stewart, Wolfgang Gaertner, Sean C Glasgow, et al.
International Journal of Nanomedicine|August 19, 2016
Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficileJohn P Hegarty, Jacek Krzeminski, Arun K Sharma, et al.
Diseases of the Colon and Rectum|December 17, 2010
Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAALiam A Haveran, Rishabh Sehgal, Lisa S Poritz, et al.
Pageof 9